The BCR-ABL oncogene requires both kinase activity and src-homology 2 domain to induce cytokine secretion

Blood

Volumn 87, Issue 1, 1996, Pages 238-244

  Anderson, Steven M ^a   Mladenovic, Jeanette ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION;

EID: 0030071777     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.238.bloodjournal871238     Document Type: Article

References (39)

1. Elefanty AG, Cory S: Hematologic disease induced in Balb/c mice by bcr-abl retrovirus is influenced by the infection conditions. Mol Cell Biol 12:1755, 1992
2. Elefanty AG, Hariharan IK, Cory S: bcr-abl, the hallmark of chronic myeloid leukemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J 9:1069, 1990
3. bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
4. Hariharan IK, Adams JM, Cory S. bcr-abl oncogene renders myeloid cell line factor independent: Potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res 3:387, 1988
5. Cook W, Metcalf D, Nicola NA, Burgess AW, Walker F: Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell 41:677, 1985
6. Pierce JH, DiFore PP, Aaronson SA, Potter M, Pumphrey J, Scott A, Ihle JN: Neoplastic transformation of mast cells by Abelson-MuLV: Abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41:685, 1985
7. Kipreos ET, Wang JYJ: Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene Oncogene Res 2:277, 1988
8. Rovera G, Valtieri M, Mavilio F, Reddy EP: Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line. Oncogene 1.29, 1987
9. Chung SW, Wong PMC, Shen-Ong G, Ruscetti S, Ishizaki T, Eaves CJ: Production of granulocyte-macrophage colony-stimulating factor by Abelson virus-induced tumorigenic mast cell lines. Blood 68:1074, 1986
10. Sirard C, Laneuville P, Dick JE: Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood 83:1575, 1994
11. McWhirter JR, Wang JYJ: An actin-binding function contributes to tranformation by the Bcr-abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J 12:1533, 1993
12. bcr/abl oncoproteins in a murine IL-3 dependent myeloid cell line Oncogene 6:275, 1991
13. Anderson SM, Carroll PM, Lee FD: Abrogation of IL-3 dependent growth requires a functional v-src gene product: Evidence for an autocrine growth cycle. Oncogene 5:317, 1989
14. Adkins B, Leutz A, Graf T: Autocrine growth induced by v-src-related oncogenes in transformed chicken myeloid cells. Cell 39:439, 1984
15. Overall RW, Watson JD, Gallis B, Weisser KE, Cosman D, Widmer MB: Nature and specificity of lymphokine independence induced by a selected retroviral vector expressing v-src. Mol Cell Biol 7:3394, 1987
16. Watson JD, Eszes M, Overall R, Conlon P, Widmer M, Gillis S: Effect of infection with marine recombinant retroviruses containing the v-src oncogene on interleukin2- and interleukin3-dependent growth states. J Immunol 139:123, 1987
17. Andrejauskas E, Moroni C: Reversible abrogation of IL-3 dependence by an inducible H-ras oncogene. EMBO J 8:2575, 1989
18. Metcalf D, Roberts TM, Cherington V, Dunn AR: The in vitro behavior of hematopoietic cells transformed by a polyoma middle T antigen parallels that of primary human myeloid leukemic cells. EMBO J 6:3703, 1987
19. Franz WM, Berger P, Wang JYJ: Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J 8:137, 1989
20. Kipreos ET, Lee GJ, Wang JYJ: Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine. Proc Natl Acad Sci USA 84:1345, 1987
21. BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene 9:149, 1994
22. Engelman A, Rosenberg N: Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis. Proc Natl Acad Sci USA 84:8021, 1987
23. Engelman A, Rosenberg N: Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity. J Virol 64:4242, 1990
24. Mayer BJ, Jackson PK, Baltimore D: The noncatalytic src homology 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci USA 88:627, 1991
25. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC: SH2 domains recognize specific phosphopeptide sequences. Cell 72:767, 1993
26. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, Ren R, Baltimore D, Patnofsky S, Feldman RA, Cantley LC: Specific motifs recognized by the SH2 domains of csk, 3BP2, fps/fes, GRB-2, HCP, SHC, syk, and vav. Mol Cell Biol 14:2777, 1994
27. Mayer BJ, Baltimore D: Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the abl tyrosine kinase. Mol Cell Biol 14:2883, 1994
28. Mayer BJ, Jackson PK, Van Etten RA, Baltimore D: Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol Cell Biol 12:609, 1992
29. Pendergast A-M, Muller AJ, Havlik MH, Maru Y, Witte O: BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66:161, 1991
30. Gliniak BC, Rohrschneider LR: Expression of the M-CSF receptor is controlled posttranscriptionally by the dominant actions of GM-CSF or multi-CSF. Cell 63:1073, 1990
31. Hansen MB, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203, 1989
32. Keating MT, Williams LT: Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science 239:914, 1988
33. Isfort RJ, Stevens D, May WS, Ihle JN: Interleukin 3 binds to a 140-kDa phosphotyrosine-containing cell surface protein. Proc Natl Acad Sci USA 85:7982, 1988
34. Sorenson P, Mui AL-F, Krystal G: Interleukin-3 stimulates the tyrosine phosphorylation of the 140-kilodalton interleukin-3 receptor. J Biol Chem 264:19253, 1989
35. BCR/ABL. J Biol Chem 269:5016, 1994
36. Bell JC, Mahadevan LC, Colledge WH, Frackelton AR, Sargent MG, Foulkes JG: Abelson-transformed fibroblasts contain nuclear phosphotyrosyl-proteins which preferentially bind to murine DNA. Nature 325:552, 1987
37. ten Hoeve J, Arlinghaus RB, Guo J, Heisterkemp N, Groffen J: Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. Blood 84:1731, 1994
38. Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P, Golde DW: Identification of CRKL as the constitutively phosphorylated 39 kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood 84:2912, 1994
39. Oda T, Tamura S, Matsuguchi T, Griffin JD, Druker BJ: The SH2 domain of ABL is not required for factor-independent growth induced by BCR-ABL in a murine myeloid cell line. Leukemia 9:295, 1995